3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
4
Li-Fraumeni Syndrome
1
Hamartoma Syndrome, Multiple
1
Carcinoma, Ductal
1
Carcinoma in Situ
1
Breast Carcinoma In Situ
1
Interventions
dodecyl maltoside
2
Magnetic Resonance Imaging
2
Electrocardiography
2
Diphenhydramine
2
Acetaminophen
2
toripalimab
1
fludarabine phosphate
1
fludarabine
1
enfortumab vedotin
1
durvalumab
1
cemiplimab
1
aldesleukin
1
Tomography, X-Ray Computed
1
Sampling Studies
1
Respiratory Function Tests
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Mitomycin
1
Meperidine
1
Mastectomy, Subcutaneous
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Hydroxyzine
1
Histamine Antagonists
1
Granisetron
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma in Situ
×
Mastectomy, Subcutaneous
×
1 year
×
Clear all
NCT02311959
2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3
Completed
450 enrolled